Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine

Clinical trial NCT00203099 · COMPLETED

Trial details

NCT number: NCT00203099
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapse Remitting Multiple Sclerosis

Start date: 2004-12-01
Primary completion: 2006-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.